Not available
Quote | Oxford Immunotec Global PLC (NASDAQ:OXFD)
Last: | $21.99 |
---|---|
Change Percent: | 0.05% |
Open: | $21.97 |
Close: | $21.99 |
High: | $21.99 |
Low: | $21.97 |
Volume: | 808,562 |
Last Trade Date Time: | 03/05/2021 04:55:48 pm |
News | Oxford Immunotec Global PLC (NASDAQ:OXFD)
Merger activity decreased last week with four new deals announced. Coherent and Aegion receive rival bids. Athene Holding to merge with Apollo Global Management. For further details see: Merger Arbitrage Mondays - Bidding Wars And Revised Agreements
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection Canada NewsWire OXFORD , United Kingdom and MARLBOROUGH, Ma...
Message Board Posts | Oxford Immunotec Global PLC (NASDAQ:OXFD)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $OXFD News Article - PerkinElmer to Acquire Oxford Immunotec Global PLC | whytestocks | investorshangout | 01/07/2021 3:25:48 PM |
BREAKING NEWS: $OXFD Oxford Immunotec Global PLC ($OXFD) | whytestocks | investorshub | 11/03/2020 11:15:23 PM |
JUST IN: $OXFD Oxford Immunotec Reports Third Quarter | whytestocks | investorshub | 11/03/2020 11:00:26 PM |
whytestocks: $OXFD News Article - Oxford Immunotec Reports Third Quarter 2020 Financial Results | whytestocks | investorshangout | 11/03/2020 4:15:51 PM |
News: $OXFD Oxford Immunotec Reports Second Quarter 2019 | whytestocks | investorshub | 08/06/2019 3:10:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Oxford Immunotec Global PLC Company Name:
OXFD Stock Symbol:
NASDAQ Market:
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection Canada NewsWire OXFORD , United Kingdom and MARLBOROUGH, Ma...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announces it has worked with GC MS and MESDIA Co., Ltd. to enter into an MOU to market t...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces an update to the configuration of the T-SPOT Discovery SARS-CoV-2 kit. Th...